Blue Cross and Blue Shield of Massachusetts reported a net loss of $222.8 million and a -2.2% profit margin in 2025, citing unprecedented medical and pharmacy spending.
The company’s annual revenue was $10.3 billion. It posted an operating loss of $380.5 million (-3.7% operating margin), and an investment income of $157.7 million. In the fourth quarter, the company reported a net loss of $121.5 million on revenue of $2.6 billion (-4.7% net margin).
In 2024, BCBSMA reported a net loss of $223.6 million (-2.3% net margin) and an operating loss of $400.4 million (-4.3% operating margin).
The company said it is “aggressively managing” administrative spending through layoffs, voluntary separations, real estate consolidation and vendor contract renegotiation. It also dropped GLP-1 coverage for weight loss last year.
At the Becker's 5th Annual Fall Payer Issues Roundtable, taking place November 2–3 in Chicago, payer executives and healthcare leaders will come together to discuss value-based care, regulatory changes, cost management strategies and innovations shaping the future of payer-provider collaboration. Apply for complimentary registration now.
